AlphAIAlphAI — Financial news for AI agents
tradingview.comOCT 201 min read$AUSI

AURA SYSTEMS INC 3Q 2026: Revenue $34K, Net income $3.396M, EPS $0.02— 10-Q Summary

AURA SYSTEMS INC reported 3Q 2026 revenue of $34K, net income of $3.396M, and EPS of $0.02, reversing a year-ago loss. Revenue remains minimal and depends on prototype completion targeted for fiscal 2027. The company is advancing product designs and R&D, with significant spending in fiscal 2026.

Original reporting
tradingview.com
Published Oct 20, 2026, 8:51 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Oct 20, 2026, 9:02 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
About AlphAI AI DeskScoring methodologyReport an issue
AURA SYSTEMS INC 3Q 2026: Revenue $34K, Net income $3.396M, EPS $0.02— 10-Q Summary — source image
Source · tradingview.com
Decision brief

The 30-second read

$AUSINeutralLow
01

Why it matters

The earnings release confirms a shift from loss to profit but with negligible revenue, suggesting limited immediate trading interest.

02

Market read

Primary disclosure of earnings for a micro‑cap; low trading relevance due to tiny revenue.

03

What to watch

Potential upside from upcoming prototype deliveries and licensing deals not reflected in current numbers.

Relevance 4/10Novelty 4/10Timing: after‑hours release

Background

Aura Systems Inc is a micro‑cap developer of power conversion products. The 10‑Q filing provides the first detailed quarterly financials for Q3 2026.

Company-level read

Ticker impact

$AUSINeutralMedium confidence
Context

Aura Systems Inc filed its 10‑Q reporting Q3 2026 revenue of $34K and a net profit of $3.396M, the first public disclosure of these results.

Expected impact

limited upside as investors weigh tiny revenue against modest profit

Evidence & confidence

The earnings are the first report but the scale ($34K revenue) is trivial, so market reaction is expected to be muted.

Market effects

Sector

No material impact on the broader clean‑energy or power‑electronics sector.

Regional

Limited to niche investors in micro‑caps; no regional effect.

Global

None

Counterpoint

What could challenge this read

If the company secures large contracts in FY2027, the modest profit could be a catalyst for a breakout.

Key entities

  • company
    Aura Systems Inc

    Micro‑cap power‑electronics manufacturer (NASDAQ: AUSI).

Read at source← All news

Related articles

OCT 21
$EFXMedAI 8/10

UBS reiterates Buy on Equifax stock, keeps $220 price target

UBS maintained a Buy rating on Equifax (NYSE:EFX) with a $220 price target, citing strong Q3 earnings and an upbeat outlook. The stock is currently at $174.53, with InvestingPro valuing it at $228.97. Equifax's government business grew to $550M in annual contract value, and its records increased 12% YoY. Analysts have mixed views on its performance, with targets ranging from $175 to $217.

investing.com2 min
OCT 21
$NFLXMed

UBS cuts Netflix stock price target on softer guidance, content concerns

UBS cut Netflix's (NFLX) price target to $100 from $115, citing softer guidance and content concerns. Q3 revenue met expectations, but Q4 guidance was weaker due to one-time expenses. The stock is near its 52-week low, down 45% over the past year. Management expects 2026 revenue at the lower end of prior guidance, with advertising revenue reduced to $2.7B. Multiple analysts adjusted price targets, with ratings ranging from Buy to Overweight.

investing.com2 min
OCT 21
$EWBCHighAI 8/10

D.A. Davidson maintains East West Bancorp stock rating on NIM beat

D.A. Davidson reiterated a Buy rating on East West Bancorp (EWBC) with a $155 price target, citing strong Q3 results driven by net interest margin expansion and upwardly revised net interest income guidance. EWBC reported Q3 earnings of $2.76 per share on $823M revenue, beating estimates. Morgan Stanley raised its price target to $168, maintaining an Overweight rating.

investing.com2 min
OCT 21
$TMOHighAI 9/10

Thermo Fisher Scientific Q3 Earnings Call Highlights

Thermo Fisher Scientific (TMO) reported Q3 revenue growth across most segments, with Life Sciences up 5%, Analytical Instruments up 6%, and Lab Products up 15%. Specialty Diagnostics saw a 6% revenue decline. Adjusted operating margins improved in all segments. The company introduced AI-enabled products and raised its 2026 revenue and EPS guidance to $47.7B-$48.2B and $25.13-$25.43, respectively. It also completed the divestiture of its microbiology business and repaid $1.1B in senior notes.

finance.yahoo.com2 min